Please login to the form below

Not currently logged in
Email:
Password:

Kala

This page shows the latest Kala news and features for those working in and with pharma, biotech and healthcare.

Sanofi’s Guillaume Pfefer joins Kala as CEO

Former Sanofi executive Guillaume Pfefer has been appointed president and CEO of Kala Pharmaceuticals. ... He said: “ Kala has developed an innovative approach to transform treatments for a range of serious diseases.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Vedanta Biosciences appoints two new heads Vedanta Biosciences appoints two new heads

    Schopf formerly served as the senior director of preclinical development at Kala Pharmaceuticals and has over 20 years of industry experience.

  • ARC names chairman and member of the board ARC names chairman and member of the board

    Iwicki is executive chairman of the board of directors of Kala Pharmaceuticals and sits on the boards of Nimbus Therapeutics and Taris Biomedical.

  • Kala names Howard Rosen as chairman Kala names Howard Rosen as chairman

    Kala names Howard Rosen as chairman. He is former CEO of Pearl Therapeutics and VP at Gilead. ... Kala's president and CEO Guillaume Pfefer commented on this rich experience when welcoming Rosen. “

  • Allergan veteran joins Kala as head of business development Allergan veteran joins Kala as head of business development

    Allergan veteran joins Kala as head of business development. Charles McDermott has experience in ophthalmology. ... Charles McDermott, who has spent the last eight years at Allergan, has joined serious disease specialist Kala Pharmaceuticals as executive

  • Kala Pharma appoints Fovea founder Bernard Gilly to board Kala Pharma appoints Fovea founder Bernard Gilly to board

    Kala Pharma appoints Fovea founder Bernard Gilly to board. He previously formed the company that became Sanofi’ s ophthalmology business. ... Dr Bernard Gilly, founder and CEO of Sanofi-owned Fovea, has joined the board of Kala Pharmaceuticals.

More from appointments
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics